US 6207170
Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
expired A61KA61K2039/55522A61K2039/55527
Quick answer
US patent 6207170 (Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes) held by Biomira USA Inc. expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Biomira USA Inc.
- Grant date
- Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/55522, A61K2039/55527, A61K2039/55533, A61K2039/5555